Human cone visual pigment deletions spare sufficient photoreceptors to warrant gene therapy
- PMID: 24067079
- PMCID: PMC3868405
- DOI: 10.1089/hum.2013.153
Human cone visual pigment deletions spare sufficient photoreceptors to warrant gene therapy
Abstract
Human X-linked blue-cone monochromacy (BCM), a disabling congenital visual disorder of cone photoreceptors, is a candidate disease for gene augmentation therapy. BCM is caused by either mutations in the red (OPN1LW) and green (OPN1MW) cone photoreceptor opsin gene array or large deletions encompassing portions of the gene array and upstream regulatory sequences that would predict a lack of red or green opsin expression. The fate of opsin-deficient cone cells is unknown. We know that rod opsin null mutant mice show rapid postnatal death of rod photoreceptors. Using in vivo histology with high-resolution retinal imaging, we studied a cohort of 20 BCM patients (age range 5-58) with large deletions in the red/green opsin gene array. Already in the first years of life, retinal structure was not normal: there was partial loss of photoreceptors across the central retina. Remaining cone cells had detectable outer segments that were abnormally shortened. Adaptive optics imaging confirmed the existence of inner segments at a spatial density greater than that expected for the residual blue cones. The evidence indicates that human cones in patients with deletions in the red/green opsin gene array can survive in reduced numbers with limited outer segment material, suggesting potential value of gene therapy for BCM.
Figures





Similar articles
-
Gene Therapy in Opn1mw-/-/Opn1sw-/- Mice and Implications for Blue Cone Monochromacy Patients with Deletion Mutations.Hum Gene Ther. 2022 Jul;33(13-14):708-718. doi: 10.1089/hum.2021.298. Epub 2022 May 16. Hum Gene Ther. 2022. PMID: 35272502 Free PMC article.
-
Human L- and M-opsins restore M-cone function in a mouse model for human blue cone monochromacy.Mol Vis. 2018 Jan 8;24:17-28. eCollection 2018. Mol Vis. 2018. PMID: 29386880 Free PMC article.
-
Gene-based Therapy in a Mouse Model of Blue Cone Monochromacy.Sci Rep. 2017 Jul 27;7(1):6690. doi: 10.1038/s41598-017-06982-7. Sci Rep. 2017. PMID: 28751656 Free PMC article.
-
Blue cone monochromacy and gene therapy.Vision Res. 2023 Jul;208:108221. doi: 10.1016/j.visres.2023.108221. Epub 2023 Mar 29. Vision Res. 2023. PMID: 37001420 Free PMC article. Review.
-
Genetics of color vision deficiencies.Dev Ophthalmol. 2003;37:170-87. doi: 10.1159/000072046. Dev Ophthalmol. 2003. PMID: 12876837 Review.
Cited by
-
Cone Photoreceptor Structure in Patients With X-Linked Cone Dysfunction and Red-Green Color Vision Deficiency.Invest Ophthalmol Vis Sci. 2016 Jul 1;57(8):3853-63. doi: 10.1167/iovs.16-19608. Invest Ophthalmol Vis Sci. 2016. PMID: 27447086 Free PMC article.
-
Rescue of M-cone Function in Aged Opn1mw-/- Mice, a Model for Late-Stage Blue Cone Monochromacy.Invest Ophthalmol Vis Sci. 2019 Aug 1;60(10):3644-3651. doi: 10.1167/iovs.19-27079. Invest Ophthalmol Vis Sci. 2019. PMID: 31469404 Free PMC article.
-
BEST1 gene therapy corrects a diffuse retina-wide microdetachment modulated by light exposure.Proc Natl Acad Sci U S A. 2018 Mar 20;115(12):E2839-E2848. doi: 10.1073/pnas.1720662115. Epub 2018 Mar 5. Proc Natl Acad Sci U S A. 2018. PMID: 29507198 Free PMC article.
-
TULP1 mutations causing early-onset retinal degeneration: preserved but insensitive macular cones.Invest Ophthalmol Vis Sci. 2014 Jul 29;55(8):5354-64. doi: 10.1167/iovs.14-14570. Invest Ophthalmol Vis Sci. 2014. PMID: 25074776 Free PMC article.
-
Evaluation of Retinal Structure and Visual Function in Blue Cone Monochromacy to Develop Clinical Endpoints for L-opsin Gene Therapy.Int J Mol Sci. 2024 Oct 2;25(19):10639. doi: 10.3390/ijms251910639. Int J Mol Sci. 2024. PMID: 39408969 Free PMC article.
References
-
- Applebury M.L., Antoch M.P., Baxter L.C., et al. (2000). The murine cone photoreceptor: a single cone type expresses both S and M opsins with retinal spatial patterning. Neuron 27, 513–523 - PubMed
-
- Ayyagari R., Kakuk L.E., Coats C.L., et al. (1999). Bilateral macular atrophy in blue cone monochromacy (BCM) with loss of the locus control region (LCR) and part of the red pigment gene. Mol. Vis. 5, 13. - PubMed
-
- Baseler H.A., Brewer A.A., Sharpe L.T., et al. (2002). Reorganization of human cortical maps caused by inherited photoreceptor abnormalities. Nat. Neurosci. 5, 364–370 - PubMed
-
- Blackwell H.R., and Blackwell O.M. (1957). Blue mono-cone monochromacy: a new color vision defect. J. Opt. Soc. Am. 47, 338
-
- Blackwell H.R., and Blackwell O.M. (1961). Rod and cone receptor mechanisms in typical and atypical congenital achromatopsia. Vis. Res. 1, 62–107
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials